arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL
$277.39 ▼ -7.80 (-2.74%) at close
Industrials ·Services-Commercial Physical & Biological Research ·USServices-Commercial Physical & Biological Research
72 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
39
Health
Weak
Bearish
auto_awesome

Analytical Summary

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. faces fundamental challenges with weakness in Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $13.3B
Dividend Yield —
Revenue Growth -2.7% ↘
Op. Margin 11.9% →
ROIC 3.3% ↗
FCF / Share $3.74 ↗
Trailing P/E —
Price / Book 4.7x
FCF Yield 1.4%
Debt / Equity —
info Valuation on last close. End-of-day price, Sep 23, 2026.

72-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.00B
↓ -2.7% —
Net Income Profit after all expenses
$-1.48M
↑ +90.0% —
Operating Margin Operating profit as % of sales
11.9%
↓ -0.8% 30th
FCF / Share Free cash flow per share
$3.74
↑ +346.0% —
Long-Term Debt Long-term obligations
$1.63B
↓ -8.1% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓
45
Returns
39
Financial Health ↓
50
Cash Quality
3

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 19 years · 72 quarters